Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
anti-CD19/BCMA CAR-T cells
BIOLOGICAL
2 trials
Sponsors
Peng Liu
, Hrain Biotechnology Co., Ltd.
Conditions
Multiple Myeloma Progression
Multiple Myeloma in Relapse
POMES Syndrome
Relapsed and Refractory POMES Syndrome
Phase 1
Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM
NCT03706547
Peng Liu
Multiple Myeloma in Relapse, Multiple Myeloma Progression
Start: 2018-10-30
End: 2021-12-31
Target: 20
Updated: 2018-10-16
Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMES
NCT03879382
Hrain Biotechnology Co., Ltd.
POMES Syndrome, Relapsed and Refractory POMES Syndrome
Start: 2019-02-27
End: 2022-05-30
Target: 10
Updated: 2021-08-06